Individual.com

For free personalized news click here!


	Top World News Business Finance Internet Computing Environmental Energy Healthcare Industry News, A-Z Sports Telecom Transportation


	Should employers hire the overqualified? Briefing.com: Bond Market Update - 08:55 ET Pratt & Whitney Rocketdyne's Space Shuttle Main Engines Deliver Hardware to Support Science Experiments Onboard the International Space Station South Bay Galleria to get another needed face lift Skateboarder's death leaves many questions Airmedia to March into Outdoor Media Field INDONESIA'S DIAN SWASTATIKE ACQUIRES COAL MINING CO FOR US$4.8 MLN 3 teens plead innocent in burning of boy BofA ends retiree match for nonprofits EU Extended Deadline For Antitrust Review Of Oracle, Sun Microsystems Deal (ORCL,JAVA)


	Antitrust Corporate Performance Stock Market Education Top World News Banking Alternative Energy Aerospace & Defense Oil & Gas Insurance

Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference

Nov, Calif., Nov. 4, 2009 (Canada NewsWire via COMTEX) --

    <<
    Proof-of-Concept Data at 12th International Conference on the Mechanisms
    and Treatment of Neuropathic Pain



    >>

Raptor Pharmaceutical Corp. (Nasdaq: RPTP), today announced that data from a clinical trial of NGX426, the Company's orally administered non-opioid, AMPA/kainate antagonist, will be presented at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November 20-21, 2009 in San Francisco.

    <<

    (Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

    >>

...

Terms of Service

Copyright , Individual.com, an Office.com Company. No redistribution allowed.